Published in

Springer Nature [academic journals on nature.com], European Journal of Human Genetics, 8(19), p. 901-907, 2011

DOI: 10.1038/ejhg.2011.48

Links

Tools

Export citation

Search in Google Scholar

Meta-analysis of genome-wide association for migraine in six population-based European cohorts

Journal article published in 2011 by Lannie Ligthart ORCID, Boukje de Vries, Eco Jc C. de Geus, B. De Vries, Albert V. Smith ORCID, Mohammad Arfan Ikram ORCID, M. Arfan Ikram, Najaf Amin, Vm Mathijs Kattenberg, Jouke-Jan Hottenga, M. H. M. De Moor, Stephany C. Koelewijn, A. J. W. Janssens, Marleen Hm Mhm de Moor, A. Cecile J. W. Janssens and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Migraine is a common neurological disorder with a genetically complex background. This paper describes a meta-analysis of genome-wide association (GWA) studies on migraine, performed by the Dutch-Icelandic migraine genetics (DICE) consortium, which brings together six population-based European migraine cohorts with a total sample size of 10,980 individuals (2446 cases and 8534 controls). A total of 32 SNPs showed marginal evidence for association at a P-value<10(-5). The best result was obtained for SNP rs9908234, which had a P-value of 8.00 × 10(-8). This top SNP is located in the nerve growth factor receptor (NGFR) gene. However, this SNP did not replicate in three cohorts from the Netherlands and Australia. Of the other 31 SNPs, 18 SNPs were tested in two replication cohorts, but none replicated. In addition, we explored previously identified candidate genes in the meta-analysis data set. This revealed a modest gene-based significant association between migraine and the metadherin (MTDH) gene, previously identified in the first clinic-based GWA study (GWAS) for migraine (Bonferroni-corrected gene-based P-value=0.026). This finding is consistent with the involvement of the glutamate pathway in migraine. Additional research is necessary to further confirm the involvement of glutamate.